{"version":"1","review_status":"no assertion criteria provided","date_last_evaluated":"2016-05-31","title":"NM_001374258.1(BRAF):c.1901A\u003eG (p.Asp634Gly) AND Squamous cell carcinoma of the head and neck","variation_archive_id":"VCV000013972","submission_count":"1","id":"RCV000435875","variation_id":"13972","interpretation":"Likely pathogenic","trait_set_id":"1717"}
{"version":"1","review_status":"no assertion criteria provided","date_last_evaluated":"2016-05-31","title":"NM_001374258.1(BRAF):c.1901A\u003eG (p.Asp634Gly) AND Lung adenocarcinoma","variation_archive_id":"VCV000013972","submission_count":"1","id":"RCV000426107","variation_id":"13972","interpretation":"Likely pathogenic","trait_set_id":"3349"}
{"version":"1","review_status":"no assertion criteria provided","date_last_evaluated":"2015-07-14","title":"NM_001374258.1(BRAF):c.1901A\u003eG (p.Asp634Gly) AND Cutaneous melanoma","variation_archive_id":"VCV000013972","submission_count":"1","id":"RCV000426339","variation_id":"13972","interpretation":"Pathogenic","trait_set_id":"12074"}
{"version":"1","review_status":"no assertion criteria provided","date_last_evaluated":"2016-05-31","title":"NM_001374258.1(BRAF):c.1901A\u003eG (p.Asp634Gly) AND Neoplasm of the large intestine","variation_archive_id":"VCV000013972","submission_count":"1","id":"RCV000443882","variation_id":"13972","interpretation":"Pathogenic","trait_set_id":"31428"}
{"version":"1","review_status":"no assertion criteria provided","date_last_evaluated":"2016-05-31","title":"NM_001374258.1(BRAF):c.1901A\u003eG (p.Asp634Gly) AND Adrenocortical carcinoma","variation_archive_id":"VCV000013972","submission_count":"1","id":"RCV000433779","variation_id":"13972","interpretation":"Likely pathogenic","trait_set_id":"35132"}
{"version":"1","review_status":"no assertion criteria provided","date_last_evaluated":"2016-05-31","title":"NM_001374258.1(BRAF):c.1901A\u003eG (p.Asp634Gly) AND Transitional cell carcinoma of the bladder","variation_archive_id":"VCV000013972","submission_count":"1","id":"RCV000437006","variation_id":"13972","interpretation":"Likely pathogenic","trait_set_id":"35142"}
{"version":"2","review_status":"criteria provided, single submitter","date_last_evaluated":"2012-06-11","title":"NM_001374258.1(BRAF):c.1901A\u003eG (p.Asp634Gly) AND Non-small cell lung cancer","variation_archive_id":"VCV000013972","submission_count":"1","id":"RCV000037932","variation_id":"13972","interpretation":"Pathogenic","trait_set_id":"4069"}
{"version":"12","review_status":"criteria provided, conflicting interpretations","date_last_evaluated":"2020-01-08","title":"NM_000038.6(APC):c.3920T\u003eA (p.Ile1307Lys) AND Familial adenomatous polyposis 1","variation_archive_id":"VCV000000822","submission_count":"6","id":"RCV000020088","variation_id":"822","interpretation":"Conflicting interpretations of pathogenicity, risk factor","trait_set_id":"6265"}
